{"count": 284, "results": [{"_id": "34065108", "pmid": 34065108, "pmcid": "PMC8126028", "title": "Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC", "journal": "Int J Mol Sci", "authors": ["Zhang Y", "Wang H", "Xiao H"], "date": "2021-05-09T00:00:00Z", "doi": "10.3390/ijms22095016", "meta_date_publication": "2021 May 9", "meta_volume": "22", "meta_issue": "9", "meta_pages": "", "score": 50285.58, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NASH@@@-Related @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@HCC@@@", "citations": {"NLM": "Zhang Y, Wang H, Xiao H. Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC Int J Mol Sci. 2021 May 9;22(9):. PMID: 34065108", "BibTeX": "@article{34065108, title={Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC}, author={Zhang Y and Wang H and Xiao H}, journal={Int J Mol Sci}, volume={22}, number={9}}"}}, {"_id": "36316840", "pmid": 36316840, "pmcid": "PMC9622616", "title": "Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology", "journal": "Medicine (Baltimore)", "authors": ["Huang Y", "Wang X", "Yan C", "Li C", "Zhang L", "Zhang L", "Liang E", "Liu T", "Mao J"], "date": "2022-10-28T00:00:00Z", "doi": "10.1097/MD.0000000000031437", "meta_date_publication": "2022 Oct 28", "meta_volume": "101", "meta_issue": "43", "meta_pages": "e31437", "score": 50283.055, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@nonalcoholic fatty liver@@@ based on meta-analysis and network pharmacology", "citations": {"NLM": "Huang Y, Wang X, Yan C, Li C, Zhang L, Zhang L, Liang E, Liu T, Mao J. Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology Medicine (Baltimore). 2022 Oct 28;101(43):e31437. PMID: 36316840", "BibTeX": "@article{36316840, title={Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology}, author={Huang Y and Wang X and Yan C and Li C and Zhang L and Zhang L and Liang E and Liu T and Mao J}, journal={Medicine (Baltimore)}, volume={101}, number={43}, pages={e31437}}"}}, {"_id": "36531446", "pmid": 36531446, "pmcid": "PMC9748475", "title": "Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study", "journal": "Front Endocrinol (Lausanne)", "authors": ["Huang KH", "Lee CH", "Cheng YD", "Gau SY", "Tsai TH", "Chung NJ", "Lee CY"], "date": "2022-11-30T00:00:00Z", "doi": "10.3389/fendo.2022.1027484", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "1027484", "score": 50281.832, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ users and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ nonusers were enrolled and matched to compare the risk of @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@.", "citations": {"NLM": "Huang KH, Lee CH, Cheng YD, Gau SY, Tsai TH, Chung NJ, Lee CY. Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study Front Endocrinol (Lausanne). 2022;13():1027484. PMID: 36531446", "BibTeX": "@article{36531446, title={Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study}, author={Huang KH and Lee CH and Cheng YD and Gau SY and Tsai TH and Chung NJ and Lee CY}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={1027484}}"}}, {"_id": "33841337", "pmid": 33841337, "pmcid": "PMC8024567", "title": "Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Lian J", "Fu J"], "date": "2021-03-24T00:00:00Z", "doi": "10.3389/fendo.2021.649018", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "649018", "score": 50274.426, "text_hl": "Therefore, current guidelines do not recommend the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for adult @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NASH@@@. ", "citations": {"NLM": "Lian J, Fu J. Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis Front Endocrinol (Lausanne). 2021;12():649018. PMID: 33841337", "BibTeX": "@article{33841337, title={Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis}, author={Lian J and Fu J}, journal={Front Endocrinol (Lausanne)}, volume={12}, pages={649018}}"}}, {"_id": "35379885", "pmid": 35379885, "pmcid": "PMC8979948", "title": "Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRalpha/PCSK9 pathway", "journal": "Sci Rep", "authors": ["Zhu W", "Ding C", "Huang P", "Ran J", "Lian P", "Tang Y", "Dai W", "Huang X"], "date": "2022-04-04T00:00:00Z", "doi": "10.1038/s41598-022-09610-1", "meta_date_publication": "2022 Apr 4", "meta_volume": "12", "meta_issue": "1", "meta_pages": "5639", "score": 50274.37, "text_hl": "Indeed, the efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@ has been established in previous studies by our group and others. ", "citations": {"NLM": "Zhu W, Ding C, Huang P, Ran J, Lian P, Tang Y, Dai W, Huang X. Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRalpha/PCSK9 pathway Sci Rep. 2022 Apr 4;12(1):5639. PMID: 35379885", "BibTeX": "@article{35379885, title={Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRalpha/PCSK9 pathway}, author={Zhu W and Ding C and Huang P and Ran J and Lian P and Tang Y and Dai W and Huang X}, journal={Sci Rep}, volume={12}, number={1}, pages={5639}}"}}, {"_id": "36077467", "pmid": 36077467, "pmcid": "PMC9456083", "title": "Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase", "journal": "Int J Mol Sci", "authors": ["Yang MH", "Li WY", "Wu CF", "Lee YC", "Chen AY", "Tyan YC", "Chen YA"], "date": "2022-09-03T00:00:00Z", "doi": "10.3390/ijms231710072", "meta_date_publication": "2022 Sep 3", "meta_volume": "23", "meta_issue": "17", "meta_pages": "", "score": 50271.023, "text_hl": "Many clinical trials have been conducted to evaluate the therapeutic effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@. ", "citations": {"NLM": "Yang MH, Li WY, Wu CF, Lee YC, Chen AY, Tyan YC, Chen YA. Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase Int J Mol Sci. 2022 Sep 3;23(17):. PMID: 36077467", "BibTeX": "@article{36077467, title={Reversal of High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Metformin Combined with PGG, an Inducer of Glycine N-Methyltransferase}, author={Yang MH and Li WY and Wu CF and Lee YC and Chen AY and Tyan YC and Chen YA}, journal={Int J Mol Sci}, volume={23}, number={17}}"}}, {"_id": "36551216", "pmid": 36551216, "pmcid": "PMC9775246", "title": "Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet", "journal": "Biomolecules", "authors": ["Baiges-Gaya G", "Rodríguez-Tomàs E", "Castañé H", "Jiménez-Franco A", "Amigó N", "Camps J", "Joven J"], "date": "2022-11-30T00:00:00Z", "doi": "10.3390/biom12121787", "meta_date_publication": "2022 Nov 30", "meta_volume": "12", "meta_issue": "12", "meta_pages": "", "score": 50269.63, "text_hl": "...3.1. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Does Not Prevent @DISEASE_Lymphoma_Non_Hodgkin @DISEASE_MESH:D008228 @@@HFHSD@@@-Associated @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@ Development and Metabolic Derangements", "citations": {"NLM": "Baiges-Gaya G, Rodríguez-Tomàs E, Castañé H, Jiménez-Franco A, Amigó N, Camps J, Joven J. Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet Biomolecules. 2022 Nov 30;12(12):. PMID: 36551216", "BibTeX": "@article{36551216, title={Combining Dietary Intervention with Metformin Treatment Enhances Non-Alcoholic Steatohepatitis Remission in Mice Fed a High-Fat High-Sucrose Diet}, author={Baiges-Gaya G and Rodríguez-Tomàs E and Castañé H and Jiménez-Franco A and Amigó N and Camps J and Joven J}, journal={Biomolecules}, volume={12}, number={12}}"}}, {"_id": "33981216", "pmid": 33981216, "pmcid": "PMC8107689", "title": "Analysis of Time Course and Dose Effect From Metformin on Body Mass Index in Children and Adolescents", "journal": "Front Pharmacol", "authors": ["Wang DD", "Mao YZ", "He SM", "Chen X"], "date": "2021-04-26T00:00:00Z", "doi": "10.3389/fphar.2021.611480", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "611480", "score": 50269.617, "text_hl": "For @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@nonalcoholic fatty liver@@@, 1,000 mg/day @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was required for at least 6.57 weeks and 26.28 weeks to achieve the plateau of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ effect. ", "citations": {"NLM": "Wang DD, Mao YZ, He SM, Chen X. Analysis of Time Course and Dose Effect From Metformin on Body Mass Index in Children and Adolescents Front Pharmacol. 2021;12():611480. PMID: 33981216", "BibTeX": "@article{33981216, title={Analysis of Time Course and Dose Effect From Metformin on Body Mass Index in Children and Adolescents}, author={Wang DD and Mao YZ and He SM and Chen X}, journal={Front Pharmacol}, volume={12}, pages={611480}}"}}, {"_id": "35326230", "pmid": 35326230, "pmcid": "PMC8945168", "title": "Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice", "journal": "Antioxidants (Basel)", "authors": ["Choi JY", "Jang TW", "Song PH", "Choi SH", "Ku SK", "Song CH"], "date": "2022-03-18T00:00:00Z", "doi": "10.3390/antiox11030580", "meta_date_publication": "2022 Mar 18", "meta_volume": "11", "meta_issue": "3", "meta_pages": "", "score": 50268.375, "text_hl": "However, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has limited efficacy in improving the histopathological changes in @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@, and the clinical evidence is still lacking. ", "citations": {"NLM": "Choi JY, Jang TW, Song PH, Choi SH, Ku SK, Song CH. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice Antioxidants (Basel). 2022 Mar 18;11(3):. PMID: 35326230", "BibTeX": "@article{35326230, title={Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice}, author={Choi JY and Jang TW and Song PH and Choi SH and Ku SK and Song CH}, journal={Antioxidants (Basel)}, volume={11}, number={3}}"}}, {"_id": "36039840", "pmid": 36039840, "title": "Advances in metformin for the treatment of non-alcoholic fatty liver disease in children.", "journal": "Expert Rev Gastroenterol Hepatol", "authors": ["Wu QL", "Zeng SX", "Peng JY", "Yuan Y", "Zhu Z", "Xie ZC", "Huang ZH", "Huang JS", "Lai JM", "Chen JA", "Lin MH"], "date": "2022-09-01T00:00:00Z", "doi": "10.1080/17474124.2022.2118112", "meta_date_publication": "2022 Sep", "meta_volume": "16", "meta_issue": "9", "meta_pages": "863-877", "score": 50266.734, "text_hl": "Advances in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for the treatment of @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@non-alcoholic fatty liver disease@@@ in children.", "citations": {"NLM": "Wu QL, Zeng SX, Peng JY, Yuan Y, Zhu Z, Xie ZC, Huang ZH, Huang JS, Lai JM, Chen JA, Lin MH. Advances in metformin for the treatment of non-alcoholic fatty liver disease in children. Expert Rev Gastroenterol Hepatol. 2022 Sep;16(9):863-877. PMID: 36039840", "BibTeX": "@article{36039840, title={Advances in metformin for the treatment of non-alcoholic fatty liver disease in children.}, author={Wu QL and Zeng SX and Peng JY and Yuan Y and Zhu Z and Xie ZC and Huang ZH and Huang JS and Lai JM and Chen JA and Lin MH}, journal={Expert Rev Gastroenterol Hepatol}, volume={16}, number={9}, pages={863-877}}"}}]}